SOLID PIGMENT PREPARATIONS CONTAINING ANIONIC AND NONIONIC SURFACE-ACTIVE ADDITIVES

Details for Australian Patent Application No. 2003257420 (hide)

Owner BASF AKTIENGESELLSCHAFT

Inventors KLOPP, Ingo; GONZALEZ GOMEZ, Juan Antonio; REISACHER, Hansulrich; STOHR, Andreas

Pub. Number AU-A-2003257420

PCT Number PCT/EP03/06409

PCT Pub. Number WO2004/000903

Priority 102 27 657.9 20.06.02 DE

Filing date 18 June 2003

Wipo publication date 6 January 2004

International Classifications

C08G 018/08 Polymeric products of isocyanates or isothiocyanates

C09D 017/00 Pigment pastes, e.g. for mixing in paints

C09B 067/00 Influencing the physical, e.g. the dyeing or printing, properties of dyestuffs without chemical reaction, e.g. by treating with solvents

A61K 007/027

A61K 007/48

A61K 007/032

C08G 018/66 Polymeric products of isocyanates or isothiocyanates

C09D 175/06 Coating compositions based on polyureas or polyurethanes - from polyesters

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 102 27 657.9 20.06.02 DE

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2003257420

19 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003257421-DRIVE DEVICE FOR OPENING OR CLOSING A DOOR OR SIMILAR

2003257419-OX40 (=CD134) receptor agonistic and therapeutic use